Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Ishita Drugs And Industries's share price is ₹75.33.
Ishita Drugs And Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹48.97. Hence, Ishita Drugs And Industries's PS Ratio for today is 1.54.
Warning Sign:
Ishita Drugs And Industries Ltd stock PS Ratio (=1.54) is close to 1-year high of 1.69.
The historical rank and industry rank for Ishita Drugs And Industries's PS Ratio or its related term are showing as below:
BOM:524400'
s PS Ratio Range Over the Past 10 Years
Min: 0.21 Med: 0.96 Max: 2.03
Current: 1.54
During the past 13 years, Ishita Drugs And Industries's highest PS Ratio was 2.03. The lowest was 0.21. And the median was 0.96.
BOM:524400's PS Ratio is ranked better than 65.51% of 951
companies
in the Drug Manufacturers industry
Industry Median: 2.33
vs BOM:524400: 1.54
Ishita Drugs And Industries Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Ishita Drugs And Industries was -2.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 1.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 10.30% per year.
During the past 13 years, Ishita Drugs And Industries's highest 3-Year average Revenue per Share Growth Rate was 36.40% per year. The lowest was -17.80% per year. And the median was 4.75% per year.
Ishita Drugs And Industries (BOM:524400) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Ishita Drugs And Industries PS Ratio Related Terms
Ishita Drugs And Industries PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ishita Drugs And Industries PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's PS Ratio distribution charts can be found below:
* The bar in red indicates where Ishita Drugs And Industries's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Ishita Drugs And Industries's Share Price of today is ₹75.33. Ishita Drugs And Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹48.97.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Ishita Drugs And Industries (BOM:524400) has a PS Ratio of 1.54 as of Aug. 15, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ishita Drugs And Industries and its competitors. This is 60% above median its historical median of 0.96. Over the past decade, Ishita Drugs And Industries' PS Ratio has ranged from 0.21 to 2.03. According to the industry distribution chart, Ishita Drugs And Industries ranks #328 out of 951 companies in the Drug Manufacturers industry, placing it in the top 34.5%.
Is Ishita Drugs And Industries' PS Ratio too high?
Ishita Drugs And Industries' current PS Ratio of 1.54 is 60% above median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 2.03. The Drug Manufacturers industry median PS Ratio is 2.33. Ishita Drugs And Industries' value of 1.54 is 33.9% below this industry median. Based on the distribution chart, Ishita Drugs And Industries ranks #328 out of 951 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ishita Drugs And Industries has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ishita Drugs And Industries ranks #328 out of 951 companies for PS Ratio. This puts Ishita Drugs And Industries in the upper half of its industry. The industry median PS Ratio is 2.33. Ishita Drugs And Industries' value of 1.54 is 33.9% below this benchmark. Historically, Ishita Drugs And Industries' own PS Ratio has ranged from 0.21 to 2.03 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 2.33, Ishita Drugs And Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.33, based on 951 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ishita Drugs And Industries's current PS Ratio of 1.54 is 33.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ishita Drugs And Industries and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current PS Ratio is 1.54, which is 60% above median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.71, compared to a current price of ₹75.33 — trading 4.3% below its estimated fair value. The current PS Ratio is 1.54, which is 60% above median its 10-year median of 0.96 and 33.9% below the Drug Manufacturers industry median of 2.33. Ishita Drugs And Industries' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current PS Ratio is 1.54 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?
Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued.
The current stock price of ₹75.33 is trading 4.3% below its estimated GF Value™ of ₹78.71.
GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.
Key valuation signals for BOM:524400:
PS Ratio: 1.54 (60% above median its 10-year median of 0.96)
GF Value™: ₹78.71 vs. price of ₹75.33 (4.3% below fair value)
Industry Position: 33.9% below the Drug Manufacturers median (#328 of 951)
No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
72GF Score
Get the complete analysis for BOM:524400
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524400 has been successfully added to your 
